Tuesday, September 1, 2020
The level of discordance between pathologists, and the differences in operationalizing liver biopsy collection in trial protocols have been frequently raised as major issues and areas of concern for NASH clinical trials.
The goal of this session was to discuss issues including: inter/intra-observer variability, scoring systems, and technical and logistical considerations.